Ph.D
Zahra Azizi is a PhD candidate in Medical Biology at Pamukkale University, Turkey. She holds an MSc in Medical Biology and a BSc in Biotechnology. Her doctoral research focuses on molecular mechanisms involved in breast cancer progression, particularly ferroptosis, oxidative stress–related signaling pathways, and therapy resistance. She has extensive hands-on experience in cancer cell culture models, molecular biology techniques, and translational cancer research. Her work aims to bridge fundamental molecular findings with potential targeted therapeutic applications in oncology.
Teaching Assistant for medical student laboratory courses (2023–2024)
Peer reviewer for:
World Journal of Gastroenterology
Oncology Research
Certified in ethical animal experimentation (PAU-HADYEK)
Active involvement in molecular and cellular oncology research projects
Dogan C, Acikbas I, Er Urganci B, Azizi Z.
The role of the NEAT1/miR-410-3p axis in the invasion of breast cancer cells.
Gene, 2025; 951:149379.
Azizi Z, Er Urganci B, Acikbas I.
Breast cancer stem cells and circulating tumor cells: Dual drivers of progression and relapse.
World Journal of Stem Cells, 2025; 17(12).
Doxorubicin Effects on Breast Cancer Proliferation via the NEAT1/miR-410-3p Axis.
Asian Pacific Journal of Cancer Prevention
Secukinumab affects the expression levels of lncRNAs MEG3 and MSX2P1 in an in vitro psoriasis model.
(Accepted)
